Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
暂无分享,去创建一个
C. Masters | A. Bush | R. Cherny | C. Mclean | S. Fuller | Colin L. Masters | Catriona A. McLean | Robert A. Cherny | Fiona W. Fraser | Stephanie J. Fuller | Margaret J. Smith | Konrad Vbeyreuther | Ashley I. Bush | Catriona A. McLean | Fiona W. Fraser | Margaret J. Smith | Colin L. Masters | Robert A. Cherny | Fiona W. Fraser | Stephanie J. Fuller | Margaret J. Smith | Konrad Vbeyreuther | Ashley I. Bush | Konrad Vbeyreuther | Catriona McLean
[1] L. Lue,et al. Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .
[2] C. Masters,et al. Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion* , 1999, The Journal of Biological Chemistry.
[3] J. Trojanowski,et al. The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic Aging , 1999, Experimental Neurology.
[4] Y. Ihara,et al. Appearance of Sodium Dodecyl Sulfate-Stable Amyloid β-Protein (Aβ) Dimer in the Cortex During Aging , 1999 .
[5] P. Greengard,et al. Generation and Regulation of β‐Amyloid Peptide Variants by Neurons , 1998 .
[6] Y. Ihara,et al. The presence of amyloid beta-protein in the detergent-insoluble membrane compartment of human neuroblastoma cells. , 1998, Biochemistry.
[7] Steven M. Horvath,et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease , 1998, Nature Genetics.
[8] T. Iwatsubo,et al. Mutant Presenilin 2 Transgenic Mouse: Effect on an Age‐Dependent Increase of Amyloid β‐Protein 42 in the Brain , 1998, Journal of neurochemistry.
[9] K Namekata,et al. Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease. , 1998, The American journal of pathology.
[10] R. Doms,et al. Detection of a Novel Intraneuronal Pool of Insoluble Amyloid β Protein that Accumulates with Time in Culture , 1998, The Journal of cell biology.
[11] Y. Ihara,et al. Amyloid β-protein (Aβ) Accumulation in the Putamen and Mammillary Body during Aging and in Alzheimer Disease , 1998 .
[12] M. Shoji,et al. Biochemical heterogeneity of Alzheimer's disease , 1998 .
[13] J. Price,et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. , 1998, Archives of neurology.
[14] B. Greenberg,et al. Turnover of Amyloid β-Protein in Mouse Brain and Acute Reduction of Its Level by Phorbol Ester , 1998, The Journal of Neuroscience.
[15] A. Roses. Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain , 1997, Neurobiology of Disease.
[16] Yasuo Ihara,et al. Amyloid β‐protein deposition in the leptomeninges and cerebral cortex , 1997 .
[17] C. Duyckaerts,et al. Diagnosis and Staging of Alzheimer Disease , 1997, Neurobiology of Aging.
[18] C. Masters,et al. Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] D. Dickson,et al. The Pathogenesis of Senile Plaques , 1997, Journal of neuropathology and experimental neurology.
[20] Brian J Cummings,et al. β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease , 1996, Neurobiology of Aging.
[21] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[22] Hans Förstl,et al. Analysis of Heterogeneous βA4 Peptides in Human Cerebrospinal Fluid and Blood by a Newly Developed Sensitive Western Blot Assay* , 1996, The Journal of Biological Chemistry.
[23] L. Forno,et al. P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain. , 1996, The American journal of pathology.
[24] M. Ball,et al. Water-soluble A(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains (*) , 1996, The Journal of Biological Chemistry.
[25] D. Mann,et al. Presence of soluble amyloid β–peptide precedes amyloid plaque formation in Down's syndrome , 1996, Nature Medicine.
[26] S. Hirai,et al. Modified Amyloid β Protein Ending at 42 or 40 with Different Solubility Accumulates in the Brain of Alzheimer′s Disease , 1995 .
[27] W. Honer,et al. Correlations of synaptic and pathological markers with cognition of the elderly , 1995, Neurobiology of Aging.
[28] N. Suzuki,et al. Biochemical evidence for the long-tail form (Aβ1-42/43) of amyloid β protein as a seed molecule in cerebral deposits of alzheimer′s disease , 1994 .
[29] M. Tabaton,et al. Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. , 1994, Biochemical and biophysical research communications.
[30] M. Ball,et al. Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. , 1994, The Journal of biological chemistry.
[31] B. Hyman,et al. The Lack of Accumulation of Senile Plaques or Amyloid Burden in Alzheimer's Disease Suggests a Dynamic Balance Between Amyloid Deposition and Resolution , 1993, Journal of neuropathology and experimental neurology.
[32] D. Selkoe,et al. beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. , 1993, The Journal of biological chemistry.
[33] Bradley T. Hyman,et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.
[34] B. Hyman,et al. Amyloid, dementia and Alzheimer's disease. , 1992, Current opinion in neurology and neurosurgery.
[35] K. Kosik,et al. Neuritic pathology and dementia in alzheimer's disease , 1991, Annals of neurology.
[36] J. Price,et al. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.
[37] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[38] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[39] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .